These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7521203)

  • 1. Clinical prognostic significance of tumour angiogenesis.
    Craft PS; Harris AL
    Ann Oncol; 1994 Apr; 5(4):305-11. PubMed ID: 7521203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of angiogenesis in human neoplasms: current prognostic and therapeutic implications.
    Fontanini G; Del Mastro L; Bevilacqua G
    Forum (Genova); 1998; 8(2):128-42. PubMed ID: 9666050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density.
    Offersen BV; Borre M; Overgaard J
    Eur J Cancer; 2003 May; 39(7):881-90. PubMed ID: 12706356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.
    Straume O; Chappuis PO; Salvesen HB; Halvorsen OJ; Haukaas SA; Goffin JR; Bégin LR; Foulkes WD; Akslen LA
    Cancer Res; 2002 Dec; 62(23):6808-11. PubMed ID: 12460889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.
    Gasparini G; Harris AL
    J Clin Oncol; 1995 Mar; 13(3):765-82. PubMed ID: 7533829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of angiogenesis in breast cancer.
    Leek RD
    Anticancer Res; 2001; 21(6B):4325-31. PubMed ID: 11908687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow.
    Weidner N
    J Pathol; 1998 Feb; 184(2):119-22. PubMed ID: 9602700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenesis in bladder: prognosis indicator and therapeutic target].
    Chabannes E; Bernardini S; Wallerand H; Bittard H
    Prog Urol; 2001 Jun; 11(3):417-27. PubMed ID: 11512452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis: a new prognostic marker for breast cancer.
    Magennis DP
    Br J Biomed Sci; 1998 Sep; 55(3):214-20. PubMed ID: 10367410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis.
    Sharma S; Sharma MC; Sarkar C
    Histopathology; 2005 May; 46(5):481-9. PubMed ID: 15842629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
    Saji S; Toi M; Tominaga T
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor and angiogenesis].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2008; 125(3):487-96; discussion 497-9. PubMed ID: 19505004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis.
    Flamini V; Jiang WG; Lane J; Cui YX
    Crit Rev Oncol Hematol; 2016 Apr; 100():177-89. PubMed ID: 26917455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.
    Bochner BH; Cote RJ; Weidner N; Groshen S; Chen SC; Skinner DG; Nichols PW
    J Natl Cancer Inst; 1995 Nov; 87(21):1603-12. PubMed ID: 7563203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer.
    Crew JP
    Eur Urol; 1999 Jan; 35(1):2-8. PubMed ID: 9933788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs.
    Fox SB; Gasparini G; Harris AL
    Lancet Oncol; 2001 May; 2(5):278-89. PubMed ID: 11905783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma.
    Lane AM; Egan KM; Yang J; Saornil MA; Alroy J; Albert D; Gragoudas ES
    Melanoma Res; 1997 Jun; 7(3):237-42. PubMed ID: 9195563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in invasive breast carcinoma--a prospective study of tumour heterogeneity.
    Ahlgren J; Risberg B; Villman K; Bergh J
    Eur J Cancer; 2002 Jan; 38(1):64-9. PubMed ID: 11750841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance?
    Miliaras D; Kamas A; Kalekou H
    Histopathology; 1995 Feb; 26(2):165-9. PubMed ID: 7537717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.